$CART Balance Sheet | Understand Stock

$CART

$60.08 -$0.80 (1.31%) Close

$CART Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023
ASSETS
Current assets:
Cash and cash equivalents
Short-term marketable securities
Accounts receivable, net of allowance of $3 and $2, respectively
Restricted cash and cash equivalents, current
Prepaid expenses and other current assets
Total current assets
Long-term marketable securities
Restricted cash and cash equivalents, noncurrent
Property and equipment, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Deferred tax assets, net
Other assets
Total assets
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued and other current liabilities
Operating lease liabilities, current
Deferred revenue
Total current liabilities
Operating lease liabilities, noncurrent
Other long-term liabilities
Total liabilities
Series A redeemable convertible preferred stock; $0.0001 par value per share; 5,833 shares authorized, issued, and outstanding as of December 31, 2025 and June 30, 2026
Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Stockholders’ equity:
Preferred stock, $0.0001 par value per share; 24,167 shares authorized as of December 31, 2025 and June 30, 2026; zero shares issued and outstanding as of December 31, 2025 and June 30, 2026
Common stock, $0.0001 par value per share; $2,000,000 shares authorized as of December 31, 2025 and June 30, 2026; 242,867 and $233,035 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively
Exchangeable shares, no par value; 702 and zero shares authorized as of December 31, 2022 and December 31, 2023, respectively; 689 and zero shares issued and outstanding as of December 31, 2022 and December 31, 2023, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity
Temporary equity, shares authorized (in shares)
Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Temporary equity, shares outstanding (in shares)
Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Temporary equity, shares issued (in shares)
Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Common stock, par or stated value per share (in dollars per share)

Comments